Fifth Third Bancorp
FLNA

Fifth Third Bancorp’s Filana Therapeutics FLNA Stock Holding History

Fifth Third Bancorp’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,120
Closed -$174K – 2614
2024
Q2 		$174K Hold
14,120
– – ﹤0.01% 1000
2024
Q1 		$286K Hold
14,120
– – ﹤0.01% 901
2023
Q4 		$318K Hold
14,120
– – ﹤0.01% 864
2023
Q3 		$235K Hold
14,120
– – ﹤0.01% 919
2023
Q2 		$346K Hold
14,120
– – ﹤0.01% 832
2023
Q1 		$341K Hold
14,120
– – ﹤0.01% 855
2022
Q4 		$417K Buy
14,120
+8,220
+139% +$295K ﹤0.01% 750
2022
Q3 		$247K Hold
5,900
– – ﹤0.01% 888
2022
Q2 		$166K Buy
+5,900
New +$149K ﹤0.01% 1006

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fifth Third Bancorp's FLNA Position: Q3 2024 in Review

Fifth Third Bancorp sold out of Filana Therapeutics (FLNA) in Q3 2024, closing a stake of 14,120 shares — an estimated $174K sold.

Fifth Third Bancorp first reported a position in FLNA in Q2 2022 and held it in 9 quarters. The position peaked at $417K in Q4 2022. 161 funds tracked by Wall St. Rank hold FLNA as of Q3 2024.

  • Fifth Third Bancorp reported no remaining Filana Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Fifth Third Bancorp sold 14,120 Filana Therapeutics shares in Q3 2024, an estimated $174K.
  • Fifth Third Bancorp first reported a position in Filana Therapeutics in Q2 2022 and held it in 9 quarters.
  • Fifth Third Bancorp's Filana Therapeutics position peaked at $417K in Q4 2022.
  • 161 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2024.

Based on Fifth Third Bancorp's 13F filing for Q3 2024, filed 17 Oct 2024.